bit.bio
bit.bio is an award-winning human synthetic biology company whose mission is to code cells for novel cures. They have developed an end-to-end platform for the creation of any human cell type. With their cutting-edge and patent-protected opti-ox™ precision cell programing technology, bit.bio can deterministically program human induced pluripotent stem cells (iPSCs) into a chosen cell identity with unprecedented biological consistency at an industrial scale and approximately 10 times faster than conventional methods. Their platform has the potential to unlock a new generation of medicines.
Latest bit.bio Content
Industry Insight
The Pathology of Proteins: A Tangled Tale of Alzheimer's
Explore the current understanding from the scientific literature on how protein misfolding, mislocalization and malfunction can lead to Alzheimer's disease.
Video
Revolutionizing In Vitro Disease Models With iPSC Reprogramming Technology
In this Teach Me in 10, we are joined by Dr. Will Bernard to get a primer on the latest innovations in in vitro human cell technology.
Video
Precision Reprogramming iPSCs To Generate a Source of Defined, Scalable Human Cells
See how bit.bio's platform uses opti-ox technology to consistently convert stem cells into defined human cells.
Poster
Discover a New Approach to Modeling Neurodegeneration
This poster demonstrates how a novel, precise and highly controlled iPSC reprogramming technology overcomes these limitations and enables the generation of mature cell types and isogenic models of neurodegenerative disease.
Poster
Optimized Human iPSC-Derived Sensory Neurons for Pain and Neuropathy Research
Many promising drugs which show efficacy in animal models have failed in the clinic due to interspecies variance in nociception mechanisms. Hence, consistent, scalable human in vitro models are required to accelerate potential therapeutics to the clinic.
Poster
Generating Pure, Consistent GABAergic Neurons From hiPSCs
While animal models and primary cells remain valuable resources, neuronal drug development faces many challenges. Not least, the variability and inaccuracy of traditional model systems can result in the failure to translate data into successful clinical trials.
Poster
Functional, Reprogrammed Microglia To Study Neurodegeneration
Microglia play key roles in neurogenesis, synaptic remodeling, and are the first responders to infection in the brain. Hence, disease-relevant cell models are key to the success of neuroimmune and neurodegeneration research.
Webinar
Driving Genome-Wide Consistency in Cellular Reprogramming
On-Demand
Biological variance poses challenges when using human iPSC-derived cells in vitro, leading to inconsistent experimental results and data variability.
Product News
bit.bio Launches New Custom Disease Model Cells Offering
bit.bio today launches its new Custom ioDisease Model CellsTM offering. This offering allows scientists to commission their disease-relevant mutation of interest in bit.bio's human induced pluripotent stem cell (iPSC)-derived cells powered by opti-ox technology.
Product
Advertisement
ioSensory Neurons: Human iPSC-Derived Neurons for Reliable Pain Research
Discover ioSensory Neurons, precision reprogrammed human iPSC-derived nociceptors from bit.bio. Don’t settle for non-human in vitro models or long, complex differentiation protocols that require toxic reagents. Start running reliable nociception assays with ioSensory Neurons today.
Advertisement
